Literature DB >> 19448536

Do osteocytes contribute to phosphate homeostasis?

Jian Q Feng1, Ling Ye, Susan Schiavi.   

Abstract

Osteocytes, the terminally differentiated cell of the osteoblast lineage, account for over 90% of all bone cells. Due to their relative inaccessibility within mineralized matrix, little is known regarding their specific functions in comparison to the well studied surface bone cells, osteoblasts and osteoclasts. Furthermore, bone is often viewed as a mineral reservoir that passively releases calcium and phosphate in response to hormones secreted from remote organs. Noncollagenous matrix proteins produced in osteocytes, such as dentin matrix protein 1 (DMP1), have also been viewed as inert scaffolds for calcium-phosphate deposition. Recent discoveries of new genetic mutations in human diseases and development of genetically engineered animal models challenge these classic paradigms, suggesting that the osteocyte plays an active role in both mineralization and total systemic phosphate regulation. In this review, we will focus on roles of osteocytes in mineralization and particularly in phosphate regulation via the DMP1- FGF23 pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448536      PMCID: PMC4005871          DOI: 10.1097/MNH.0b013e32832c224f

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  46 in total

1.  In vitro and in vivo study on osteocyte-specific mechanical signaling pathways.

Authors:  W Yang; I Kalajzic; Y Lu; D Guo; M A Harris; J Gluhak-Heinrich; L F Bonewald; J Q Feng; D W Rowe; S E Harris
Journal:  J Musculoskelet Neuronal Interact       Date:  2004-12       Impact factor: 2.041

2.  Mechanosensation and Transduction in Osteocytes.

Authors:  Lynda F Bonewald
Journal:  Bonekey Osteovision       Date:  2006-10

Review 3.  Endocrine functions of bone in mineral metabolism regulation.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

4.  Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.

Authors:  D M Kates; D J Sherrard; D L Andress
Journal:  Am J Kidney Dis       Date:  1997-12       Impact factor: 8.860

5.  The parathyroid is a target organ for FGF23 in rats.

Authors:  Iddo Z Ben-Dov; Hillel Galitzer; Vardit Lavi-Moshayoff; Regina Goetz; Makoto Kuro-o; Moosa Mohammadi; Roy Sirkis; Tally Naveh-Many; Justin Silver
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

7.  Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Hejing Wang; Robert M Elashoff; Shobha Sahney; Barbara Gales; Harald Jüppner; Isidro B Salusky
Journal:  J Clin Endocrinol Metab       Date:  2008-12-02       Impact factor: 5.958

8.  Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

Authors:  Yuji Yamazaki; Taro Tamada; Noriyuki Kasai; Itaru Urakawa; Yukiko Aono; Hisashi Hasegawa; Toshiro Fujita; Ryota Kuroki; Takeyoshi Yamashita; Seiji Fukumoto; Takashi Shimada
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

Review 9.  Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.

Authors:  Shiguang Liu; Aditi Gupta; L Darryl Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-07       Impact factor: 2.894

10.  Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.

Authors:  Alexander G Robling; Paul J Niziolek; Lee A Baldridge; Keith W Condon; Matthew R Allen; Imranul Alam; Sara M Mantila; Jelica Gluhak-Heinrich; Teresita M Bellido; Stephen E Harris; Charles H Turner
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

View more
  12 in total

Review 1.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

Review 2.  FGF23 and the parathyroid glands.

Authors:  Justin Silver; Tally Naveh-Many
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

3.  Glucocorticoid dose determines osteocyte cell fate.

Authors:  Junjing Jia; Wei Yao; Min Guan; Weiwei Dai; Mohammad Shahnazari; Rekha Kar; Lynda Bonewald; Jean X Jiang; Nancy E Lane
Journal:  FASEB J       Date:  2011-06-24       Impact factor: 5.191

Review 4.  Autophagy as a target for glucocorticoid-induced osteoporosis therapy.

Authors:  Gengyang Shen; Hui Ren; Qi Shang; Ting Qiu; Xiang Yu; Zhida Zhang; Jinjing Huang; Wenhua Zhao; Yuzhuo Zhang; Xiaobing Jiang
Journal:  Cell Mol Life Sci       Date:  2018-02-09       Impact factor: 9.261

5.  Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23.

Authors:  Yinshi Ren; Xianglong Han; Yan Jing; Baozhi Yuan; Huazhu Ke; Min Liu; Jian Q Feng
Journal:  Matrix Biol       Date:  2015-12-22       Impact factor: 11.583

6.  Phosphorus metabolism in chronic kidney disease.

Authors:  C Fourtounas
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

7.  Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice.

Authors:  Chelsea M Heveran; Charles A Schurman; Claire Acevedo; Eric W Livingston; Danielle Howe; Eric G Schaible; Heather B Hunt; Adam Rauff; Eve Donnelly; R Dana Carpenter; Moshe Levi; Anthony G Lau; Ted A Bateman; Tamara Alliston; Karen B King; Virginia L Ferguson
Journal:  Bone       Date:  2019-05-02       Impact factor: 4.398

Review 8.  Phosphate Metabolism in Health and Disease.

Authors:  Munro Peacock
Journal:  Calcif Tissue Int       Date:  2020-04-07       Impact factor: 4.333

Review 9.  Alpha Klotho and phosphate homeostasis.

Authors:  A Bian; C Xing; M C Hu
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

10.  DMP1 C-terminal mutant mice recapture the human ARHR tooth phenotype.

Authors:  Baichun Jiang; Zhengguo Cao; Yongbo Lu; Carol Janik; Stephanie Lauziere; Yixia Xie; Anne Poliard; Chunlin Qin; Leanne M Ward; Jian Q Feng
Journal:  J Bone Miner Res       Date:  2010-10       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.